Omnicell Inc

Omnicell maintains a conservative capital structure with $196.52 million in cash and equivalents and $167.596 million in long-term debt, yielding a debt-to-equity ratio of 0.14 and a current ratio of 1.43. The company's liquidity position is assessed as low risk, with no immediate filing-based liquidity flags detected. The price-to-book ratio of 1.64 suggests market valuation is modestly above tangible asset value. Profitability metrics show a return on equity of 0.17% and return on assets of 0.1%, both significantly below the industry median for Advanced Medical Equipment & Technology firms. Operating income of $5.16 million and net income of $2.05 million indicate thin margins, with a gross profit margin of 42.9% (calculated from $508.043 million gross profit on $1.185 billion revenue). Geographic and segment exposure is not explicitly disclosed in the available data, but the company's revenue concentration appears to be in the U.S. healthcare market. No material international operations or segment-specific revenue breakdowns are provided in the latest financial filing. Growth trajectory analysis shows no explicit revenue growth rates in the provided data, but the company's forward-looking price targets (mean $61.29, median $60.00) suggest analyst expectations for value creation. The high price-to-earnings ratio of 984.23 and ev/ebitda of 385.80 indicate current valuation is heavily forward-looking. Risk assessment reveals low dilution risk with no filing-based flags detected. The company's capital expenditure of -$60.363 million (net cash inflow) suggests asset sales or divestitures rather than expansion. No dilutive financing activities are disclosed in the latest period. Recent events include no material filings or transcripts in the provided data. The company's 10-K and 10-Q filings would be required to identify specific regulatory or operational developments. Analysts have issued 8 positive recommendations (7 buys, 1 strong buy) with a mean price target of $61.29, indicating strong near-term confidence.